General Information
|
|
Product
|
CCR5 Antibody BIOTIN-Conjugated
|
Description
|
BIOTIN-Conjugated Chemokine receptor type 5 Antibody
|
Verified Applications
|
ELISA, IHC, IP, WB
|
Host
|
Rabbit
|
Species Cross Reactivity
|
Human, Monkey, Rat
|
Immunogen
|
Synthetic peptide taken within amino acid region 1-50 on human CCR5 protein.
|
Accession #
|
NCBI: AAB65720.1
|
Physical Properties
|
|
Quantity
|
100 µg
|
Volume
|
200 µl
|
Concentration
|
0.64-0.70 µg/µl in antibody stabilization buffer
|
Form
|
BIOTIN-Conjugated
|
Clonality
|
Polyclonal
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
|
DB
|
1:10,000
|
ELISA
|
1:10,000
|
Immunohistochemistry |
1:100 |
Immunoprecipitation |
1:200 |
Western Blot
|
1:500
|
Protein
|
|
Uniprot #
|
P51681
|
Overview
|
Receptor for several inflammatory C-C chemokines. May play a role in control of granulocytic lineage proliferation or differentiation.
|
Molecular Function
|
actin binding; C-C chemokin binding; GPCR; Receptor; Transducer; Host-virus interaction
|
Subcellular Location
|
Cell membrane; Mulipass membrane protein.
|
Expression
|
Spleen, Thymus, myeloid cell line THP-1, promyeloblastic cell line KG-1a and on CD4+ and CD8+ T-cells. Lesser expressed in peripheral blood leukocytes, small intestine and ovary and lung.
|
Structure
|
Interacts with PRAF2, HIV-1 surface protein gp120. Glycosylation on Ser-6 is required for binding with CCL4.
|
Alternative Nomenclature
|
AM4 7 antibody
CCCKR 5 antibody
CD 195 antibody
CHEMR13 antibody
HIV 1 Fusion Coreceptor antibody
IDDM22 antibody
MIP-1 alpha receptor antibody
|